{
    "filename": "S0024320520302253.pdf",
    "content_type": "text/html",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.1016/j.lfs.2020.117477",
            "url": "https://dx.doi.org/10.1016/j.lfs.2020.117477"
        },
        "doi": "10.1016/j.lfs.2020.117477",
        "title": "Anti-HCV, nucleotide inhibitors, repurposing against COVID-19",
        "journal": "Life Sciences",
        "volume": "248",
        "abstract": "Aims\nA newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp).",
        "author": "Abdo A. Elfiky",
        "date": 2020,
        "pages": "117477",
        "references": "",
        "references_ris": "",
        "links": [],
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "aims": [
            "A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp)."
        ],
        "methods": [
            "In this study, sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin.    Key findings<br/><br/>The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease.    Significance<br/><br/>The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs. Besides, the study presents some drugs that previously proved its efficiency against the newly emerged viral infection."
        ]
    },
    "structured_content": {
        "Abstract": [],
        "Aims": [
            "A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp)."
        ],
        "Materials and methods": [
            "In this study, sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. Additionally, the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin."
        ],
        "Key findings": [
            "The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease.",
            "The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs. Besides, the study presents some drugs that previously proved its efficiency against the newly emerged viral infection."
        ]
    },
    "participants": [
        {
            "participant": "confirmed cases",
            "number": 80000,
            "context": "A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). <mark class=\"stats\">Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries</mark>. Human to human transmission is confirmed for COVID-19 by China a month ago"
        },
        {
            "participant": "reported cases",
            "number": 2500,
            "context": "Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. <mark class=\"stats\">Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases</mark>. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp)"
        }
    ],
    "statistics": [],
    "keywords": [
        "nucleotide inhibitor",
        "current study",
        "hcv drug",
        "sars hcov",
        "world health organization",
        "Human Coronavirus",
        "COVID-19",
        "RNA dependent RNA polymerase",
        "human transmission",
        "mers hcov"
    ],
    "keyword_relevance": {
        "Human Coronavirus": 0.2857142857142857,
        "COVID-19": 0.2857142857142857,
        "RNA dependent RNA polymerase": 0.2857142857142857,
        "current study": 0.047619047619047616,
        "human transmission": 0.047619047619047616,
        "World Health Organization": 0.047619047619047616,
        "nucleotide inhibitor": 0.0,
        "hcv drug": 0.0,
        "sars hcov": 0.0,
        "world health organization": 0.0,
        "mers hcov": 0.0
    },
    "species": [],
    "summary": [
        "IDX-184 may be used as a seed to obtain a potent inhibitor specific against COVID-19 RdRp. A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19).",
        "Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries.",
        "Human to human transmission is confirmed for COVID-19 by China a month ago.",
        "Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths.",
        "MERS HCoV is responsible for 858 deaths out of about 2500 reported cases.",
        "The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp).",
        "Materials and methods",
        "Sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin.",
        "The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease.",
        "The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs.",
        "The study presents some drugs that previously proved its efficiency against the newly emerged viral infection."
    ],
    "structured_summary": {
        "Introduction": [
            "IDX-184 may be used as a seed to obtain a potent inhibitor specific against COVID-19 RdRp. A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19).",
            "Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries."
        ],
        "Results": [
            "Human to human transmission is confirmed for COVID-19 by China a month ago.",
            "Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths.",
            "MERS HCoV is responsible for 858 deaths out of about 2500 reported cases.",
            "The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp).",
            "Materials and methods",
            "Sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RdRp. the newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin.",
            "The results suggest the effectiveness of Sofosbuvir, IDX-184, Ribavirin, and Remidisvir as potent drugs against the newly emerged HCoV disease."
        ],
        "Conclusion": [
            "The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs.",
            "The study presents some drugs that previously proved its efficiency against the newly emerged viral infection."
        ]
    },
    "reference_links": [],
    "facts": [
        "MERS HCoV is responsible for 858 deaths",
        "docking are used to build a model for Wuhan COVID-19 RdRp",
        "newly emerged Wuhan HCoV RdRp model is targeted by anti-polymerase drugs",
        "The results suggest the effectiveness of Sofosbuvir",
        "The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico",
        "IDX-184 may be used as a seed to obtain a potent inhibitor specific"
    ],
    "claims": [
        "The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp)",
        "The present study presents a perfect model for COVID-19 RdRp enabling its testing in silico against anti-polymerase drugs"
    ],
    "findings": [],
    "processes": [],
    "key_statements": [
        "IDX-184 may be used as a seed to obtain a potent inhibitor specific against COVID-19 RNA dependent RNA polymerase",
        "MERS Human Coronavirus is responsible for 858 deaths out of about 2500 reported cases",
        "The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp)",
        "Sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RNA dependent RNA polymerase",
        "The newly emerged Wuhan Human Coronavirus RNA dependent RNA polymerase model is targeted by anti-polymerase drugs, including the approved drugs Sofosbuvir and Ribavirin",
        "The present study presents a perfect model for COVID-19 RNA dependent RNA polymerase enabling its testing in silico against anti-polymerase drugs"
    ],
    "top_statements": [
        "IDX-184 may be used as a seed to obtain a potent inhibitor specific against COVID-19 RNA dependent RNA polymerase",
        "MERS Human Coronavirus is responsible for 858 deaths out of about 2500 reported cases",
        "The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp)",
        "Sequence analysis, modeling, and docking are used to build a model for Wuhan COVID-19 RNA dependent RNA polymerase",
        "The present study presents a perfect model for COVID-19 RNA dependent RNA polymerase enabling its testing in silico against anti-polymerase drugs"
    ],
    "headline": "The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase",
    "contexts": [],
    "abbreviations": {
        "HCoV": "Human Coronavirus",
        "WHO": "World Health Organization",
        "RdRp": "RNA dependent RNA polymerase"
    }
}
